Clinical Trial Details
| Trial ID: | L0901 |
| Source ID: | NCT00150540 |
| Associated Drug: | Lanthanum Carbonate |
| Title: | A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol. |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Kidney Failure, Chronic |
| Interventions: | DRUG: Lanthanum carbonate |
| Outcome Measures: | Primary: Treatment emergent adverse events, Up to 24 months | Secondary: Changes in pre-dialysis serum phosphate levels, Baseline, Months 3, 6, 9, 12, 15, 18, 21, 24.|Control of pre-dialysis serum phosphate levels, Baseline, Months 3, 6, 9, 12, 15, 18, 21, 24.|Plasma lanthanum levels, Baseline, Months 3, 6, 9, 12, 15, 18, 21, 24. |
| Sponsor/Collaborators: | Sponsor: Shire |
| Gender: | ALL |
| Age: | CHILD, ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 93 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2002-10-14 |
| Completion Date: | 2005-06-29 |
| Results First Posted: | |
| Last Update Posted: | 2021-06-23 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT00150540 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|